Prof Patrice Lalive: Clinical Trials

1 trial sponsored by Prof Patrice Lalive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Prof Patrice Lalive: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
recombinant zoster vaccine - Shingles, Zoster
Phase 4UnknownProf Patrice Lalive1002022-12-012024-04-10

Conditions studied

Herpes Zoster (1)  ·  Multiple Sclerosis (1)

Countries

Switzerland (1)

Top investigators

Arnaud Didierlaurent, Pr (1)  ·  Patrice Lalive, Pr (1)